Abstract
Solid organ transplant recipients are susceptible to a wide array of opportunistic infections. In this chapter we will focus on some of the more uncommon infectious diseases—nocardiosis, toxoplasmosis, pneumocystis, and Chagas disease. Given the generally low incidence yet deadly outcomes in transplant recipients, it is important for transplant professionals to be aware of assessing epidemiologic risk (particularly in Chagas disease), clinical presentation, and prevention strategies that we can employ. Donor-derived infections may occur in the case of toxoplasmosis and Chagas disease, and it is important to consider these early—patients may not be considered typical hosts, and other organ recipients may also be at risk. Many of these organisms may not be easily identified under standard microbiologic methods. As new methods evolve, it is important for us to keep abreast of these. Finally, once identified, we will review some of the best treatment regimens.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44:1307–14.
Uhde KB, Pathak S, McCullum I Jr, et al. Antimicrobial-resistant nocardia isolates, United States, 1995-2004. Clin Infect Dis. 2010;51:1445–8.
Hwang JH, Koh WJ, Suh GY, et al. Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient. Intern Med. 2004;43:852–4.
Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7:213–64.
Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2007;51:1102–4.
Uttamchandani RB, Daikos GL, Reyes RR, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis. 1994;18:348–53.
Wilson JP, Turner HR, Kirchner KA, Chapman SW. Nocardial infections in renal transplant recipients. Medicine (Baltimore). 1989;68:38–57.
Fishman JA. Pneumocystis carinii and parasitic infections in transplantation. Infect Dis Clin N Am. 1995;9:1005–44.
Dhakal R, Gajurel K, Montoya JG. Toxoplasmosis in the non-orthotopic heart transplant recipient population, how common is it? Any indication for prophylaxis? Curr Opin Organ Transplant. 2018;23(4):407–16.
Derouin F, Pelloux H, ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–101.
Schwartz BS, Mawhorter SD, AST Infectious Diseases Community of Practice. Parasitic infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):280–303.
Shingde R, Habachou LI, Calisa V, et al. Unexpected donor-derived infectious transmissions by kidney transplantation: a systematic review. Transpl Infect Dis. 2018;20:e12851.
Radisic M, Linares L. Parasites after hematopoietic stem cell or solid organ transplantation. In: Ljungman P, editor. Transplant infections. 4th ed. Basel: Springer; 2016. p. 795–820.
Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group. Am J Transplant. 2011;11:672–80.
Balderramo D, Bonisconti F, Alcaraz A, et al. Chagas disease and liver transplantation: experience in Argentina using real-time quantitative PCR for early detection and treatment. Transpl Infect Dis. 2017;19(6):e12782.
Cura CI, Lattes R, Nagel C, et al. Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. Am J Transplant. 2013;13:3253–61.
Morillo CA, Waskin H, Sosa-Estani S, et al. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers: the STOP-CHAGAS trial. J Am Coll Cardiol. 2017;69:939–47.
Martin SI, Fishman JA, AST Infectious Diseases Community of Practice. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):272–9.
Yiannakis EP, Boswell TC. Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control. J Hosp Infect. 2016;93:1–8.
Radisic M, Lattes R, Chapman JF, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis. 2003;5:84–93.
Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation. Clin Transpl. 2012;26:E184–90.
Diken AI, Diken OE, Hanedan O, et al. Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients. World J Transplant. 2016;6:193–8.
Diri R, Anwer F, Yeager A, Krishnadasan R, McBride A. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2016;18:63–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chin-Hong, P., Radisic, M. (2019). Prevention and Treatment of Other Opportunistic Infections: Nocardiosis, Toxoplasmosis, Chagas and Pneumocystis Disease. In: Manuel, O., Ison, M. (eds) Infectious Diseases in Solid-Organ Transplant Recipients. Springer, Cham. https://doi.org/10.1007/978-3-030-15394-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-15394-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15393-9
Online ISBN: 978-3-030-15394-6
eBook Packages: MedicineMedicine (R0)